ipilimumab,nivolumab,
bms,delcath systems
['chopin']
$dcth positive initial results from chopin phase 1b trial, focus trial update and qol study presented at the 2022 asco annual meeting 
Free Stock Market News are delayed 15 sec. Full features and live news available here: https://t.co/fWRacb3Vft